STAAR Surgical Price to Free Cash Flow Ratio 2012-2025 | STAA
Historical price to free cash flow ratio values for STAAR Surgical (STAA) since 2012.
| STAAR Surgical Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-03-13 | 18.84 | 0.00 | |
| 2025-09-30 | 26.87 | $-0.79 | 0.00 |
| 2025-06-30 | 16.78 | $-0.88 | 0.00 |
| 2025-03-31 | 17.63 | $-0.64 | 0.00 |
| 2024-12-31 | 24.29 | $-0.16 | 0.00 |
| 2024-09-30 | 37.15 | $0.53 | 69.69 |
| 2024-06-30 | 47.61 | $0.27 | 174.01 |
| 2024-03-31 | 38.28 | $0.43 | 89.92 |
| 2023-12-31 | 31.21 | $-0.07 | 0.00 |
| 2023-09-30 | 40.18 | $-0.68 | 0.00 |
| 2023-06-30 | 52.57 | $-0.01 | 0.00 |
| 2023-03-31 | 63.95 | $0.34 | 188.03 |
| 2022-12-31 | 48.54 | $0.36 | 136.12 |
| 2022-09-30 | 70.55 | $0.46 | 155.02 |
| 2022-06-30 | 70.93 | $0.48 | 148.08 |
| 2022-03-31 | 79.91 | $0.37 | 213.43 |
| 2021-12-31 | 91.30 | $0.61 | 148.94 |
| 2021-09-30 | 128.53 | $0.90 | 143.29 |
| 2021-06-30 | 152.50 | $0.69 | 222.34 |
| 2021-03-31 | 105.41 | $0.59 | 179.97 |
| 2020-12-31 | 79.22 | $0.26 | 302.71 |
| 2020-09-30 | 56.56 | $0.05 | 1243.08 |
| 2020-06-30 | 61.54 | $0.07 | 881.66 |
| 2020-03-31 | 32.26 | $0.14 | 237.56 |
| 2019-12-31 | 35.17 | $0.33 | 105.05 |
| 2019-09-30 | 25.78 | $0.23 | 111.12 |
| 2019-06-30 | 29.38 | $0.20 | 146.53 |
| 2019-03-31 | 34.19 | $0.16 | 207.46 |
| 2018-12-31 | 31.91 | $0.23 | 137.25 |
| 2018-09-30 | 48.00 | $0.21 | 223.46 |
| 2018-06-30 | 31.00 | $0.12 | 266.78 |
| 2018-03-31 | 14.80 | $0.10 | 143.13 |
| 2017-12-31 | 15.50 | $0.04 | 351.47 |
| 2017-09-30 | 12.45 | $0.01 | 0.00 |
| 2017-06-30 | 10.80 | $-0.04 | 0.00 |
| 2017-03-31 | 9.80 | $0.02 | 422.41 |
| 2016-12-31 | 10.85 | $-0.05 | 0.00 |
| 2016-09-30 | 9.40 | $-0.11 | 0.00 |
| 2016-06-30 | 5.51 | $-0.11 | 0.00 |
| 2016-03-31 | 7.39 | $-0.14 | 0.00 |
| 2015-12-31 | 7.14 | $-0.11 | 0.00 |
| 2015-09-30 | 7.76 | $-0.18 | 0.00 |
| 2015-06-30 | 9.66 | $-0.21 | 0.00 |
| 2015-03-31 | 7.43 | $-0.28 | 0.00 |
| 2014-12-31 | 9.11 | $-0.32 | 0.00 |
| 2014-09-30 | 10.63 | $-0.19 | 0.00 |
| 2014-06-30 | 16.80 | $-0.12 | 0.00 |
| 2014-03-31 | 18.80 | $-0.06 | 0.00 |
| 2013-12-31 | 16.19 | $0.00 | 0.00 |
| 2013-09-30 | 13.54 | $-0.03 | 0.00 |
| 2013-06-30 | 10.15 | $-0.03 | 0.00 |
| 2013-03-31 | 5.63 | $0.00 | 0.00 |
| 2012-12-31 | 6.10 | $0.03 | 233.72 |
| 2012-09-30 | 7.56 | $0.06 | 121.74 |
| 2012-06-30 | 7.77 | $0.06 | 139.75 |
| 2012-03-31 | 10.83 | $0.09 | 125.64 |
| 2011-12-31 | 10.49 | $0.12 | 87.71 |
| 2011-09-30 | 7.80 | $0.13 | 58.91 |
| 2011-06-30 | 5.30 | $0.09 | 57.55 |
| 2011-03-31 | 5.57 | $-0.08 | 0.00 |
| 2010-12-31 | 6.10 | $-0.14 | 0.00 |
| 2010-09-30 | 5.41 | $-0.11 | 0.00 |
| 2010-06-30 | 5.72 | $-0.11 | 0.00 |
| 2010-03-31 | 3.82 | $0.00 | 0.00 |
| 2009-12-31 | 3.10 | $0.03 | 112.32 |
| 2009-09-30 | 4.08 | $-0.03 | 0.00 |
| 2009-06-30 | 2.41 | $-0.10 | 0.00 |
| 2009-03-31 | 1.00 | $-0.20 | 0.00 |
| 2008-12-31 | 2.38 | $-0.30 | 0.00 |
| 2008-09-30 | 4.49 | $-0.39 | 0.00 |
| 2008-06-30 | 3.10 | $-0.38 | 0.00 |
| 2008-03-31 | 2.58 | $-0.43 | 0.00 |
| 2007-12-31 | 2.64 | $-0.42 | 0.00 |
| 2007-09-30 | 3.00 | $-0.36 | 0.00 |
| 2007-06-30 | 3.82 | $-0.37 | 0.00 |
| 2007-03-31 | 5.51 | $-0.32 | 0.00 |
| 2006-12-31 | 7.01 | $-0.35 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.801B | $0.314B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $114.495B | 24.87 |
| Cardinal Health (CAH) | United States | $51.955B | 22.98 |
| Becton Dickinson (BDX) | United States | $50.083B | 12.65 |
| West Pharmaceutical Services (WST) | United States | $18.021B | 34.36 |
| Cooper (COO) | United States | $16.264B | 20.09 |
| Align Technology (ALGN) | United States | $13.401B | 22.75 |
| Henry Schein (HSIC) | United States | $9.205B | 16.22 |
| Merit Medical Systems (MMSI) | United States | $4.842B | 23.81 |
| DENTSPLY SIRONA (XRAY) | United States | $2.583B | 8.20 |
| CONMED (CNMD) | United States | $1.294B | 9.07 |
| Pro-Dex (PDEX) | United States | $0.127B | 15.07 |
| Lifevantage (LFVN) | United States | $0.064B | 6.62 |
| Axe Compute (AGPU) | United States | $0.008B | 0.00 |